|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100048003 |
|
最近更新日期: Date of Last Refreshed on: |
2022-01-17 10:47:45 |
|
注册时间: Date of Registration: |
2021-06-28 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
1H-MRS检测严重骨性II类错颌脑组织代谢及其与上气道生理关联机制 |
|
Public title: |
1H-MRS detects the brain tissue metabolism of severe skeletal Class II malocclusion and the mechanism of its association with upper airway physiology |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
1H-MRS检测严重骨性II类错颌脑组织代谢及其与上气道生理关联机制 |
|
Scientific title: |
1H-MRS detects the brain tissue metabolism of severe skeletal Class II malocclusion and the mechanism of its association with upper airway physiology |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
洪柳 |
研究负责人: |
郭泾 |
|
Applicant: |
Hong Liu |
Study leader: |
Guo Jing |
|
申请注册联系人电话: Applicant telephone: |
+86 574 55332238 |
研究负责人电话: Study leader's telephone: |
+86 574 56121719 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
nbhr@eetop.com |
研究负责人电子邮件: Study leader's E-mail: |
guojing@sdu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省宁波市海曙区新星路435号 |
研究负责人通讯地址: |
浙江省宁波市海曙区新星路435号 |
|
Applicant address: |
435 Xinxing Road, Haishu District, Ningbo, Zhejiang, China |
Study leader's address: |
435 Xinxing Road, Haishu District, Ningbo, Zhejiang, China |
|
申请注册联系人邮政编码: Applicant postcode: |
315000 |
研究负责人邮政编码: Study leader's postcode: |
315000 |
|
申请人所在单位: |
宁波口腔医院 |
||
|
Applicant's institution: |
Ningbo Stomatology Hospital |
||
|
研究负责人所在单位: |
宁波口腔医院 |
||
|
Affiliation of the Leader: |
Ningbo Stomatology Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
NBKQYY2021LS-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
宁波口腔医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics committee of Ningbo Stomatology Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-04-30 00:00:00 |
||
|
伦理委员会联系人: |
潘梦琦 |
||
|
Contact Name of the ethic committee: |
Pan Mengqi |
||
|
伦理委员会联系地址: |
浙江省宁波市海曙区新星路435号 |
||
|
Contact Address of the ethic committee: |
435 Xinxing Road, Haishu District, Ningbo, Zhejiang, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 15037389371 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
宁波口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Ningbo Stomatology Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省宁波市海曙区新星路435号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
435 Xinxing Road, Haishu District, Ningbo, Zhejiang, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
宁波市“泛3315计划”卫生健康创新人才计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Ningbo |
||||||||||||||||||||||
|
Target disease: |
Obstructive sleep apnea and hypo-apnea syndrome ,OSAHS |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
诊断性病例对照试验 |
||||||||||||||||||||||
|
Study design: |
Diagnostic test: case-control |
||||||||||||||||||||||
|
研究目的: |
本研究将在前期研究工作基础上,运用1H-MRS检测关键区域代谢因子的谱峰及比值,靶向支持可能存在的神经元或神经胶质的损伤,预见严重骨性II类错颌有关的OSAHS导致的神经系统损害,及其与上气道生理的关联机制;期待通过观察不同治疗策略治疗骨性II类错颌畸形给上气道生理及中枢神经系统代谢因子定量评价的差异性影响,探索骨性II类错颌畸形引发OSAHS的病理生理,得出牙颌面改变与上气道生理变化之间的规律,为临床优化治疗策略提供循证医学的证据。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the previous research work, this study will use 1H-MRS to detect the peaks and ratios of metabolic factors in key areas, target support for possible neuronal or glial damage, and predict severe skeletal Class II malocclusion related The nervous system damage caused by OSAHS and its associated mechanism with upper airway physiology; expect to observe the differential influence of different treatment strategies on the quantitative evaluation of upper airway physiology and central nervous system metabolic factors in the treatment of skeletal class II malocclusion. Exploring the pathophysiology of OSAHS caused by skeletal Class II malocclusion, drawing up the rules between dento-maxillofacial changes and upper airway physiological changes, and providing evidence-based medicine for clinical optimization of treatment strategies. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
骨性I类,严重骨性II类,18岁~45岁 |
||||||||||||||||||||||
|
Inclusion criteria |
Bone Class I, Severe Bone Class II, 18 to 45 years old |
||||||||||||||||||||||
|
排除标准: |
体块指数(身高/体重2)>30;伴有糖尿病、高血压、心脑血管疾病等系统性疾病;唇腭裂;扁桃体、腺样体疾病 |
||||||||||||||||||||||
|
Exclusion criteria: |
Body mass index (height/weight2)> 30; accompanied by systemic diseases such as diabetes, hypertension, cardiovascular and cerebrovascular diseases; cleft lip and palate; tonsil and adenoid diseases |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2022-01-01 00:00:00 至 To 2022-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
no |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
投稿 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
submit a piece of writing for publication |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |